Comprehensive Clinicopathologic and Updated Immunohistochemical Characterization of Primary Ovarian Mucinous Carcinoma

SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type

(2016) Michelle Moh et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas

(2016) Claire Carleton et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Immunohistochemical characterization of appendiceal mucinous neoplasms and the value of special AT-rich sequence-binding protein 2 in their distinction from primary ovarian mucinous tumours

(2016) Sarah Strickland et al.   HISTOPATHOLOGY

Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas

(2016) Peter F Rambau et al.   HISTOPATHOLOGY

An Immunohistochemical Algorithm for Ovarian Carcinoma Typing

(2016) Martin Köbel et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary

(2016) Sarah Strickland et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

The value of SATB2 in the differential diagnosis of intestinal-type mucinous tumors of the ovary: primary vs metastatic

(2015) Delia Perez Montiel et al.   Annals of Diagnostic Pathology

Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary

(2015) Leslie Stewart Massad et al.   GYNECOLOGIC AND OBSTETRIC INVESTIGATION

Immunophenotypic Analysis in Early Müllerian Serous Carcinogenesis

(2015) Houman Nafisi et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method

(2015) Wan-Ru Chao et al.   PLoS One

Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary

(2014) Koah R. Vierkoetter et al.   GYNECOLOGIC ONCOLOGY

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma

(2014) Jacob Elebro et al.   Journal of Translational Medicine

Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms

(2012) Daichi Maeda et al.   ADVANCES IN ANATOMIC PATHOLOGY

Prevalence of Loss of Expression of DNA Mismatch Repair Proteins in Primary Epithelial Ovarian Tumors

(2012) Fang-I Lu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas

(2012) Michael S Anglesio et al.   JOURNAL OF PATHOLOGY

Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

(2012) Eleftherios P Samartzis et al.   MODERN PATHOLOGY

Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing

(2012) Bojana Djordjevic et al.   MODERN PATHOLOGY

Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma

(2012) Jian Huang et al.   NATURE GENETICS

Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma

(2011) Bin Guan et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

(2011) Kristina Magnusson et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors

(2011) Anna R. Laury et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers

(2011) B. Guan et al.   CANCER RESEARCH

Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: Implications for surgical staging

(2011) Cecelia A. Powless et al.   GYNECOLOGIC ONCOLOGY

Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types

(2011) Siân Jones et al.   HUMAN MUTATION

Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

(2011) Atsuko Katagiri et al.   MODERN PATHOLOGY

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations

(2011) Sohei Yamamoto et al.   MODERN PATHOLOGY

An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

(2011) A Mamo et al.   ONCOGENE

HER2 Expression in Gastric and Gastroesophageal Junction Adenocarcinoma in a US Population

(2011) Pamela L. Kunz et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal

(2010) Richard J. Zaino et al.   CANCER

Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas

(2010) Martin Köbel et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Primary Ovarian Mucinous Carcinoma of Intestinal Type: Significance of Pattern of Invasion and Immunohistochemical Expression Profile in a Series of 31 Cases

(2010) Ali Dastranj Tabrizi et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma

(2010) Daichi Maeda et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Calculator for ovarian carcinoma subtype prediction

(2010) Steve E Kalloger et al.   MODERN PATHOLOGY

Prevalence of Lymph Node Metastasis in Primary Mucinous Carcinoma of the Ovary

(2010) Kathleen M. Schmeler et al.   OBSTETRICS AND GYNECOLOGY

HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

(2009) Jessica N McAlpine et al.   BMC CANCER